Paladin, Pharmaplan Pty Ltd., Litha Healthcare deal

Paladin completed its acquisition of the 55.01% of drug distributor Pharmaplan it does not already own. Litha then completed its acquisition of 100% of Pharmaplan from Paladin in a stock and cash deal...